Possis Logo Printer Friendly Version

Download Financials

2005 Annual Report

Introduction
Thrombus Basics
Proprietary Technology
Market Presence
Business Model
Plans for Growth
Expanding Markets
Shareholder Letter
Glossary
Company Info

Sound management practices

Sound management practices delivered Possis into the ranks of the 50 fastest growing technology companies in Minnesota early in 2005. It earned us a spot in the 2005 Deloitte Technology Fast 500, a ranking of the 500 top-performing technology companies in North America. It fueled profitability for 19 consecutive quarters – and counting. It kept Possis in a leadership position since the introduction of our AngioJet technology. And it will continue to drive our growth and sustain our success in the future.

We’re committed to growing strategically, maintaining conservative fiscal policies, and reinvesting in our business through new science and products. Our style is steady and strategic, from growing our sales force to expanding our core technology. Our sustainable business model has yielded the resources and financial strength to fund more clinical science, pursue new vascular market opportunities, and continue to grow our product portfolio.

 

“Thrombus complicates coronary interventions and is a predictor of poor patient outcomes. The AngioJet Thrombectomy System is well established as the device of choice for treating patients with larger thrombus. I’ve also found it to be very effective at removing thrombus and establishing flow to the coronary arteries before performing aggressive procedures such as stent placement. I consider this application of AngioJet to be good practice in appropriately selected patients.”

Issam Moussa, MD
Associate Professor of Clinical Medicine,
Co-Director of Endovascular Services
at the Center for Interventional
Vascular Therapy
Columbia University Medical Center